These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35366765)

  • 1. Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer.
    Kalave S; Hegde N; Juvale K
    Curr Pharm Des; 2022; 28(38):3140-3157. PubMed ID: 35366765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
    Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y
    Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
    Yadav P; Ambudkar SV; Rajendra Prasad N
    J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
    Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
    Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy.
    Bhusare N; Gade A; Kumar MS
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23732. PubMed ID: 38769657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and strategies to overcome multiple drug resistance in cancer.
    Ozben T
    FEBS Lett; 2006 May; 580(12):2903-9. PubMed ID: 16497299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
    Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.
    Mir SA; Hamid L; Bader GN; Shoaib A; Rahamathulla M; Alshahrani MY; Alam P; Shakeel F
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.